Vaccine against lipopolysaccharide core

   
   

Compare core LPS (lacking O-polysaccharide side chains) from Gram-negative bacteria are incorporated into a vaccine typically in liposomes. The complete core of E. coli K 12 is particularly useful. Upon administration to a mammal the vaccine stimulates synthesis of antibodies which are cross-protective against smooth and rough forms of LPS from at least two different Gram-negative bacterial strains having different core structures.

 
Web www.patentalert.com

< Prevention of preservative uptake into biomaterials

< Porous silica substrates for polymer synthesis and assays

> Bone-pathobolism treating agent

> Dentifrice compositions comprising a stable low water, phase comprising polyphosphate and ionic active ingredients

~ 00117